PRESS-RELEASE ·Filed Oct 1, 2026
Press release · Earnings
Actionable Insight • Neutral
Monitor upcoming quarterly results or pipeline updates for any strategic shifts under the new CFO. The appointment is routine and does not signal a change in company direction.
Latest settled — T+5d ⚠ clustered
NBTX ▼ -8.04% at T+5d
NEUTRAL call -8.04% · α vs SPY -9.20% · entry $25.75 → $23.68
Latest observation: T+15 +31.60% FF3 residual α
T+1d
-2.52%
call -2.52% · α -3.20%
$25.10
settled 24d ago
T+5d
-8.04%
call -8.04% · α -9.20%
$23.68
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Nanobiotix announced the appointment of Arnd Christ as CFO, replacing Bart Van Rhijn. The filing is a routine executive change with no financial data or earnings results provided, making it a neutral event with minimal immediate impact.
Key Facts
- Arnd Christ appointed CFO effective October 1, 2026, succeeding Bart Van Rhijn after 5 years of service.
- Christ brings 25+ years of CFO experience at public and private biotech firms, including Immatics N.V., InflaRx N.V., and MediGene AG.
- No financial results, guidance, or material business updates were included in the press release.
Financial Impact
No financial impact disclosed; executive change only.
Risk Factors
- No immediate risks identified from this filing alone.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3373402 |
25 reports for NBTX
70% Hit rate @ T+20 Went positive at some point 7 of 10 best @ T+20▲ +55.06%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+20 | — | — |
Oct 20, 2026 6d ago | 6-K | $25.83 | awaiting T+20 | — | $31.53 (+22.07%) |
Oct 1, 2026 25d ago | 6-K | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Oct 1, 2026 25d ago | Press Release | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▲ +11.86% | ▲ +10.38% | $31.53 (+5.34%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 24, 2026 4w ago | Press Release | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 22, 2026 4w ago | Press Release | $35.24 $25.83 | ▼ −26.70% | ▼ −27.39% | $31.53 (−10.53%) |
Sep 14, 2026 6w ago | 6-K | $35.73 $23.40 | ▼ −34.51% | ▼ −36.77% | $31.53 (−11.75%) |
Jul 31, 2026 12w ago | 6-K | $38.89 $40.64 | ▲ +4.50% | ▲ +3.26% | $31.53 (−18.93%) |
Showing 10 of 25
US Market Status
Market Closed — Opens Tue (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers